NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development

Front Endocrinol (Lausanne). 2023 Jun 2:14:1176566. doi: 10.3389/fendo.2023.1176566. eCollection 2023.

Abstract

Introduction: During the development of Autoimmune Diabetes (AD) an autoimmune attack against the Peripheral Nervous System occurs. To gain insight into this topic, analyses of Dorsal Root Ganglia (DRG) from Non-Obese Diabetic (NOD) mice were carried out.

Methods: Histopathological analysis by electron and optical microscopy in DRG samples, and mRNA expression analyzes by the microarray technique in DRG and blood leukocyte samples from NOD and C57BL/6 mice were performed.

Results: The results showed the formation of cytoplasmic vacuoles in DRG cells early in life that could be related to a neurodegenerative process. In view of these results, mRNA expression analyses were conducted to determine the cause and/or the molecules involved in this suspected disorder. The results showed that DRG cells from NOD mice have alterations in the transcription of a wide range of genes, which explain the previously observed alterations. In addition, differences in the transcription genes in white blood cells were also detected.

Discussion: Taken together, these results indicate that functional defects are not only seen in beta cells but also in DRG in NOD mice. These results also indicate that these defects are not a consequence of the autoimmune process that takes place in NOD mice and suggest that they may be involved as triggers for its development.

Keywords: NOD mouse/mice; autoimmune diseases/disorders; dorsal root ganglion; neural regulation; neurodegeneration; parasympathetic function; type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 1* / metabolism
  • Ganglia, Spinal / metabolism
  • Ganglia, Spinal / pathology
  • Gene Expression
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • RNA, Messenger / metabolism

Substances

  • RNA, Messenger

Grants and funding

This work was supported by the Plan Nacional de I+D+i of the Spanish Ministry of Science and Innovation (SAF2016-77227-R and PID2019-109302RB-I00), CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM) that is an initiative from Instituto de Salud Carlos III (Spain). MC-P, BA and LE-M were supported by pre-doctoral fellowships from the University of Lleida and the IRBLleida. ER-M was supported by predoctoral fellowships from the Generalitat de Catalunya (AGAUR FI-DGR), the Spanish Government (FPU) and IRBLleida.